UBV
IRD

United Bank (Virginia)’s Opus Genetics IRD Stock Holding History

United Bank (Virginia)’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-11,800
Closed -$35.5K – 156
2023
Q4 		$35.5K Hold
11,800
– – ﹤0.01% 142
2023
Q3 		$39.5K Hold
11,800
– – 0.01% 141
2023
Q2 		$51.2K Hold
11,800
– – 0.01% 149
2023
Q1 		$44.3K Buy
+11,800
New +$42.4K 0.01% 155

Other funds holding IRD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

United Bank (Virginia)'s IRD Position: Q1 2024 in Review

United Bank (Virginia) sold out of Opus Genetics (IRD) in Q1 2024, closing a stake of 11,800 shares — an estimated $35.5K sold.

United Bank (Virginia) first reported a position in IRD in Q1 2023 and held it in 4 quarters. The position peaked at $51.2K in Q2 2023. 49 funds tracked by Wall St. Rank hold IRD as of Q1 2024.

  • United Bank (Virginia) reported no remaining Opus Genetics position as of Q1 2024 after selling out during the quarter.
  • United Bank (Virginia) sold 11,800 Opus Genetics shares in Q1 2024, an estimated $35.5K.
  • United Bank (Virginia) first reported a position in Opus Genetics in Q1 2023 and held it in 4 quarters.
  • United Bank (Virginia)'s Opus Genetics position peaked at $51.2K in Q2 2023.
  • 49 funds tracked by Wall St. Rank held Opus Genetics as of Q1 2024.

Based on United Bank (Virginia)'s 13F filing for Q1 2024, filed 13 May 2024.